Race Oncology Limited

Race Oncology Limitedverified

RAC.AX

Price:

$1.28

Market Cap:

$222.35M

Race Oncology Limited operates as a precision oncology company in Australia. The company is developing Zantrene, a potent small molecule inhibitor of the fatso/fat mass and obesity associated protein to treat for melanoma and clear cell renal cell carcinoma, as well as acute myeloid leukaemia, breast, and ovarian cancers, which is in Phase II/III clinical trial. It has a preclinical research program with the University of Newcastle for investigating Zantrene; and strategic collaboration with the University of Wollongong to evaluate Zantrene formulations. The company was formerly known as Coronado Resources Limited and changed its name to Race Oncology Limited in July 2016. Race Oncology Limi...[Read more]

Industry

Biotechnology

IPO Date

2016-07-13

Stock Exchange

ASX

Ticker

RAC.AX

The PE Ratio as of January 2025 (TTM) for Race Oncology Limited (RAC.AX) is -16.00

According to Race Oncology Limited’s latest financial reports and current stock price. The company's current PE Ratio is -16.00. This represents a change of 49.80% compared to the average of -10.68 of the last 4 quarters.

Race Oncology Limited (RAC.AX) Historical PE Ratio (quarterly & annually)

How has RAC.AX PE Ratio performed in the past?

The mean historical PE Ratio of Race Oncology Limited over the last ten years is -21.70. The current -16.00 PE Ratio has changed 7.27% with respect to the historical average. Over the past ten years (40 quarters), RAC.AX's PE Ratio was at its highest in in the September 2014 quarter at 0. The PE Ratio was at its lowest in in the December 2014 quarter at -259.69.

Quarterly (TTM)
Annual

Average

-21.70

Median

-19.66

Minimum

-75.81

Maximum

-1.22

Race Oncology Limited (RAC.AX) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Race Oncology Limited PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 1.49%

Maximum Annual PE Ratio = -1.22

Minimum Annual Increase = -93.52%

Minimum Annual PE Ratio = -75.81

Quarterly (TTM)
Annual
YearPE RatioChange
2024-21.668.75%
2023-19.92-25.35%
2022-26.69-64.80%
2021-75.81290.73%
2020-19.401.49%
2019-1.22-45.56%
2018-2.24-21.09%
2017-2.84-93.52%
2016-43.921.23%
2015-3.31-89.50%

Race Oncology Limited (RAC.AX) Average PE Ratio

How has RAC.AX PE Ratio performed in the past?

The current PE Ratio of Race Oncology Limited (RAC.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-22.76

5-year avg

-32.70

10-year avg

-21.70

Race Oncology Limited (RAC.AX) PE Ratio vs. Peers

How is RAC.AX’s PE Ratio compared to its peers?

Race Oncology Limited’s PE Ratio is less than Imugene Limited (-2.09), less than Incannex Healthcare Limited (-2.67), less than Paradigm Biopharmaceuticals Limited (-2.05), less than Recce Pharmaceuticals Ltd (-5.49), less than Antisense Therapeutics Limited (0),

Build a custom stock screener for Race Oncology Limited (RAC.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Race Oncology Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Race Oncology Limited (RAC.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Race Oncology Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Race Oncology Limited's PE Ratio?

How is the PE Ratio calculated for Race Oncology Limited (RAC.AX)?

What is the highest PE Ratio for Race Oncology Limited (RAC.AX)?

What is the 3-year average PE Ratio for Race Oncology Limited (RAC.AX)?

What is the 5-year average PE Ratio for Race Oncology Limited (RAC.AX)?

How does the current PE Ratio for Race Oncology Limited (RAC.AX) compare to its historical average?